Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.
Clearside Biomedical a company with revolutionary innovations and a future in the Medical sector.
-Revolutionary treatments:Clearside Biomedical $CLSD is developing innovative treatments for serious diseases of the posterior segment of the eye to restore and preserve vision, which may represent an attractive investment opportunity.
- Success in the US market: Their flagship... Read more
